Skip to main content
Veterinary Medicines

Procaine HCl 2 % Oplossing voor injectie

Not authorised
  • Procaine hydrochloride

Product identification

Medicine name:
Procaine HCl 2 % Oplossing voor injectie
Procaine HCl 2 % Solution injectable
Procaine HCl 2 % Injektionslösung
Active substance:
  • Procaine hydrochloride
Target species:
  • Sheep
  • Cattle
  • Pig
  • Dog
  • Horse
  • Cat
Route of administration:
  • Epidural use
  • Subcutaneous use
  • Perineural use

Product details

Active substance and strength:
  • Procaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Epidural use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Dog
  • Subcutaneous use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Dog
    • Cat
  • Perineural use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BA02
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Procaine HCl 12 Vials with 500 ml of Solution for injection
  • Procaine HCl 12 Vials with 250 ml of Solution for injection
  • Procaine HCl 12 Vials with 100 ml of Solution for injection
  • Procaine HCl 12 Vials with 50 ml of Solution for injection
  • Procaine HCl 1 Vial with 500 ml of Solution for injection
  • Procaine HCl 1 Vial with 250 ml of Solution for injection
  • Procaine HCl 1 Vial with 100 ml of Solution for injection
  • Procaine HCl 1 Vial with 50 ml of Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V104361
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."